A collaboration between Europe and Africa
DIDIDA is a consortium of 14 partners from eight countries: Kenya, Senegal, Tanzania, Uganda, the United Kingdom, France, the Netherlands, and Italy and with extensive expertise in bioengineering, digital healthcare services and diseases research, and a strong African involvement.
The partners of the consortium
Innotrope is leading the project management, dissemination, exploitation and communication activities of the DIDIDA project.
From the research and innovation cluster of Paris Saclay in France, Innotrope provides scientists and businesses from all over Europe with knowledge-based services and consulting to bridge the gap between research and commercial exploitation of innovative technologies or services.
For more information: www.innotrope.com
University of Glasgow
The scientific coordination of the DIDIDA project is led by the University of Glasgow. Working in Uganda, the UoG have pioneered low-cost, paper-based, lateral flow nucleic acid (DNA and RNA) tests powered by mobile phones to identify malaria in rural, resource-poor villages. They have also implemented m-Health platforms with deep-learning diagnostic decision support tools, validated for malaria DNA diagnostics, with geo-tagged data, using blockchain security to secure data storage in the cloud.
In 2021, the University of Glasgow received a Queen’s Anniversary Prize for its national service to the Covid-19 pandemic.
For more information: https://www.gla.ac.uk/research
Amsterdam Institute for Global Health & Development (AIGHD)
The Amsterdam Institute for Global Health & Development is a research and education institute with a mission to address challenges in global health and development by conducting collaborative interdisciplinary research, generating insights and solutions, and educating the next generation of global health leaders.
AIGHD conducts collaborative, interdisciplinary research prioritizing infectious disease elimination, antimicrobial drug resistance, chronic care & ageing, urbanization & health, health markets, and economics of human development. It aims to educate and inspire the next generation of global health leaders at undergraduate, post-graduate and professional levels to shape a healthier and more prosperous future for all. AIGHD aspires to accelerate progress on global health objectives by sharing knowledge and insights with global agencies, governments, NGOs and the scientific community.
For more information: https://www.aighd.org
African Population and Health Research Center (APHRC)
APHRC is the continent’s premier research institution and think tank exploring questions of population health and wellbeing. The Center’s mission is to generate evidence, strengthen research and related capacity in the African research and development (R&D) ecosystem and engage policy to inform action on health and development.
The African Population and Health Research Center (APHRC) is registered as a non-profit organization with 501 (c) (3) status.
Headquartered in Nairobi, Kenya with a West Africa office in Dakar, Senegal, APHRC seeks to drive change with evidence led by a growing cadre of research leaders from across Africa. Research agendas are oriented to global and continental development priorities, driven by the belief that Africa and African-generated evidence must be at the forefront of decisions supporting improved growth and development.
APHRC’s program priorities are Health and Wellbeing, Human Development, Population Dynamics and Urbanization, and Data Science and Evaluation thematic areas. Research conducted explores how improving outcomes in the above areas is linked to development and growth on the continent, and how those improved outcomes can help to shape policy, advance domestic resource mobilization and enhance implementation of best practices at national level. In recognition of its outstanding work and contribution to research on sexual and reproductive health, gender equality, and population, the Center was the institutional laureate for the 2015 UN Population Award. Since 2017, APHRC has consistently been ranked among the top think tanks worldwide by the Think Tanks and Civil Societies Program of the Lauder Institute at the University of Pennsylvania.
For more information: https://aphrc.org
Biostructures and Biosystems National Institute (INBB)
The Biostructures and Biosystems National Institute is a national consortium with the membership of 23 Italian Universities. Since 1995 it has been operating under the Italian Ministry for Universities and Research supervision. The INBB scientific activities include Bioinstruments and Bioelectronics, Biomolecules, Biotechnologies, Biosystems and Bioregulations.
More than 600 researchers adhere to INBB. INBB headquarter is in Rome (Italy), whereas the Catania INBB unit at the University of Catania (UNICT) contributes to DI-DIDA scientific activities. UNICT is also involved in DI-DIDA as an INBB-affiliated entity. UNICT-INBB unit is a cross-disciplinary team with a plurennial experience in Surface Plasmon Resonance imaging bioanalytical detection. Research interests focus on developing plasmonic-based biosensors and microfluidic-based platforms for innovative detection strategies with applications in diagnostics.
For more information: http://www.inbb.it/en/
Global Access Diagnostics (GADx)
Leveraging our core technology platforms and expertise, we work with companies, researchers and clinicians to help them deliver fast, reliable and accurate diagnosis at the point-of-care. We then facilitate local manufacturing and/or onward distribution throughout the world, with a focus on low- and middle-income countries.
GADx was formed by the acquisition of two companies, Mologic and Global Access Diagnostics, by a consortium of social impact investors called Global Access Health. As part of this transition, GADx became a social enterprise, dedicating its profits and mission to improving the health and wellbeing of underserved populations around the world. We are headquartered in Bedford in the United Kingdom and have a US subsidiary situated in Maine, New Gloucester.
For more information: www.globalaccesdx.com
The network now consists of 33 institutions in 25 countries and more than 23,000 employees.
Along with research, knowledge transfer is a crucial mission of the Institut Pasteur. Its Education Centre receives every year 900 students with more than 300 PhD students in Paris. Furthermore, the Institut Pasteur is also concerned about the need of scientific innovation and technology transfer, acting as an incubator for several start-ups.
For more information: https://www.pasteur.fr/fr
Institut Pasteur de Dakar
Since its founding in 1896, IPD has been at the forefront of the fight against infectious diseases in West Africa. It is one of only four manufacturers worldwide to be prequalified by WHO for yellow fever vaccine.
For more information: http://www.pasteur.sn
PharmAccess aims to make inclusive health markets work in Sub-Saharan Africa. The PharmAccess integrated approach addresses both the demand and supply side of the health care system and uses the opportunities that mobile technology and data provide to leapfrog development in health markets in sub-Saharan Africa. With the aim to inspire viable and resilient health markets that provide access to care for millions of people in Africa.
Through public-private partnerships, PharmAccess focusses on promoting health insurance plans and other innovative demand-side financing options to protect people from financial hardship; introducing quality standards and improvement methodologies for health care providers; loans, business support, and investments for private health care providers, and introducing value-based health care solutions to empower patients, doctors and financiers alike.
For more information: https://www.pharmaccess.org
Kenya Medical Research Institute (KEMRI)
KEMRI has grown from its humble beginning over 40 years ago to become a regional leader in human health research. The Institute currently ranks as one of the leading Centres of excellence in health research both in Africa as well as globally.
The Kenya Medical Research Institute (KEMRI) is a State Corporation established in Kenya in 1979 through the Science and Technology (Repealed) Act, Cap 250 of the Laws of Kenya operated under the Science Technology and Innovation Act, 2013 as the national body responsible for carrying out research in human health in Kenya. Currently, KEMRI operates under Legal Notice No. 35 of March 2021.
For more information: https://www.kemri.go.ke
Kilimanjaro Clinical Research Institute (KCRI)
The KCRI was launched in 2009 as the third and youngest pillar of the three Good Samaritan Foundation (GSF) under the Kilimanjaro Christian Medical Centre (KCMC). KCRI has grown as academic centre for evidence based health interventions in which investigators initiate and conduct medical research to develop evidence for interventions in improving health outcomes and provide research training and necessary research infrastructures and logistics to students, collaborators and partners.
KCRI offers a diversified and flexible exposure to both clinical and biomedical research areas in a typical tropical setting.
The institute has been participating in infectious disease studies including clinical trials, febrile illness, Bacterial zoonosis, antimicrobial resistance as well as non communicable diseases. In Di-Dida KCRI will work with other partners in development, validation and implementation of the diagnostic test for infectious and non communicable disease.
For more information: http://www.kcmc.ac.tz
The Medical Research Council & Uganda Virus Research Institute
The Medical Research Council (MRC) & Uganda Virus Research Institute (UVRI) and London School of Hygiene & Tropical Medicine (LSHTM) Uganda Research Unit is an internationally recognized centre of excellence for research and training.
Established in 1988 following a request from the Uganda Government to the United Kingdom (UK) Government, our mission is to conduct high-quality research that adds knowledge and leads to improved control of infectious and non-communicable diseases in Uganda, Africa and globally, through translation of scientific findings into policy and practice, and rigorous research capacity building. Over 100 scientists across our three top-notch research facilities in central and south western Uganda deliver research projects of the highest quality, ranging from basic science and epidemiology, to rigorous clinical trials for the prevention and management of diseases of public health importance in Africa. In the last five years, we have trained 58 Master’s and 44 PhD students, many from Uganda, but also from other African countries and the UK. Our research and capacity building success are in part because we have been able to attract strategic collaborations in the UK and other countries.
For more information: https://www.uvri.go.ug
Strathmore University Business School
Strathmore University Business School is one of the Schools in Strathmore University that endeavors to transform leadership in Africa. Strathmore Business School (SBS) has taken the responsibility of influencing the leadership of public and private sectors across the continent since its inception in 2005.
The Institute of Healthcare Management (IHM) housed at Strathmore University Business School continues to play a leading role in research and research capacity strengthening within the Business School.
First, it is involved in the design and execution of world class academic and executive training Programmes. Secondly, the Institute is involved in securing scholarships, PhD training slots, various ongoing and inception-stage research projects and publications. In addition, it achieves its mandate through close collaboration with several universities, donors and research institutes both locally and abroad.
For more information: https://strathmore.edu
Ugandan Ministry of Health
Vector Borne & Neglected Tropical Disease Control Division, Uganda Ministry of Health
Uganda has a high burden of Neglected Tropical Diseases (NTDs). These affect mainly the rural poor and result in reduced productivity, hence affecting the development of these populations. Currently, there are on-going efforts to prevent, control and eliminate these NTDs in the country with varying degrees of success. NTD control is part of the Uganda National Minimum Health Care Package as highlighted in the Health Sector Strategic and Investment Plan.
The NTDs of the highest public health importance in the country include Lymphatic Filariasis (Elephantiasis), Schistosomiasis (Bilharzia), soil-transmitted Helminths (Intestinal Worms), Onchocerciasis (River blindness), Trachoma, Human African Trypanosomiasis (Sleeping sickness), Visceral Leishmaniasis (Kala-azar), Plague, Buruli Ulcer Disease (BUD), Rabies, Tungiasis (Jiggers), Podoconiosis (non Filarial Elephantiasis), Echinoccosis, Cysticercosis, brucellosis and Leprosy. In addition to this, Uganda is in the post-certification phase for Guinea worm.
Control of NTDs will contribute to improved health and socioeconomic situation of the affected populations.
For more information: https://www.health.go.ug
Want to know more?
Are you a student and you want to learn more? A researcher seeking to consult our publications? A citizen eager to better understand the issues? A decision-maker who can promote this innovation? A journalist looking for an engaging story to tell?